Mathews Journal of Case Reports

2474-3666

Previous Issues Volume 8, Issue 12 - 2023

Nutrivigilance: Boon for the Safety and Efficacy of Nutraceuticals Formulations

Mohammad Nadeem Khan1,*, Ashok Kumar2, Praveen Chand Dubey3, Mohammad Rafi4

1Department of Pharmacology, Clinical Pharmacology, SAMC&PGI, Sri Aurobindo University, Indore, Madhya Pradesh, India

2Department of Pharmacology, SAMC&PGI, Sri Aurobindo University, Indore, Madhya Pradesh, India

3Chairman SEAC, Government of Madhya Pradesh Bhopal Madhya Pradesh, India

4ADR Monitoring center (PvPi, Ghaziabad), Department of Pharmacology, SAMC&PGI, Indore, Madhya Pradesh, India

*Corresponding Author: Mohammad Nadeem Khan, Department of Pharmacology, Clinical Pharmacology, SAMC&PGI, Sri Aurobindo University, Indore, Madhya Pradesh, India; Email: [email protected]

Received Date: December 01, 2023

Publication Date: December 14, 2023

Citation: Khan MN, et al. (2023). Nutrivigilance: Boon for the Safety and Efficacy of Nutraceuticals Formulations. Mathews J Case Rep. 8(12):141.

Copyright: Khan MN, et al. © (2023)

ABSTRACT

Nutrivigilance is a corrective process originating in interactions between nutraceuticals formulations and human populations, investigating, in real situations of life, benefits, risks and use of nutraceuticals. Supplements include substances such as vitamins, minerals, botanicals, and amino acids. Although many of these supplements can be beneficial, there are risks correlated with some. For example, ginkgo biloba may lead to excessive bleeding, vitamin A in high dosages during pregnancy may lead to birth defects, and St. John’s Wort may reduce the effectiveness of some antiviral formulations. Unlike new prescription and over-the-counter drugs or formulations, FDA does not have the authority to require supplements to undergo premarket approval for safety and efficacy. This is of major concern now a day to monitor the safety and adverse drug reactions (ADRs) related with the use of the Nutraceuticals”. The USFDA, IPC and other country continuous ADR monitoring Nutraceuticals together became as a WHO Collaborating Centre. The Nutravigilance Programme of India encourages all healthcare professionals and consumers to report ADRs associated with nutraceuticals. We may be integrating the all stockholder to monitoring Programme of nutraceutical formulations adverse event monitor very precisely that are helpful to nutraceutical formulations compliance with more satisfied quality control and quality assurance and safe for consumer.

Keywords: Adverse drug reaction, Awareness, Nutraceutical formulations, Nutravigilance, Safety


Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com